Pharmaceuticals & Biotechnology (4570)

20,752.30
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

GSK, Spero UTI drug trial ends early after meeting target

By Frank Prenesti

Date: Wednesday 28 May 2025

Pharmaceuticals & Biotechnology ShareCast News

4basebio reports strong full-year progress 27-May-2025 ShareCast
Avacta pushes back annual results due to auditor... 27-May-2025 ShareCast
EU recommends AstraZeneca bladder cancer treatme... 27-May-2025 ShareCast
Poolbeg Pharma extends cash runway after raising... 23-May-2025 ShareCast
GSK's COPD treatment approved by FDA 23-May-2025 ShareCast

Pharmaceuticals & Biotechnology Regulatory News

Form 8.3 - BENCHMARK HOLDINGS PLC 28-May-2025 12:38 RNS
GSK stops Phase 3 trial on cUTIs for efficacy 28-May-2025 12:00 RNS
Form 8.3 - BENCHMARK HOLDINGS PLC 28-May-2025 11:06 RNS
Form 8.3 - Benchmark Holdings plc 28-May-2025 10:49 RNS
Form 8.3 - [BENCHMARK HOLDINGS PLC - Opening Dis... 28-May-2025 09:10 GlobeNewswire NA

Pharmaceuticals & Biotechnology Newspaper Links

Small companies roundup: Sinclair IS Pharma cons... 27-Nov-2014 Express & Star
MARKET REPORT: Buyers lining up for Sinclair sal... 26-Nov-2014 Daily Mail
Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
AstraZeneca buys the rights to an asthma treatme... 13-Jun-2014 Daily Mail
AstraZeneca in new £138million asthma drug deal 13-Jun-2014 Express & Star

Pharmaceuticals & Biotechnology Tips & Analysis

Questor :GW Pharmaceuticals 04-Dec-2014 Telegraph
Questor : Hikma Pharmaceuticals 13-Mar-2014 Telegraph
Investment Column:BTG 06-Oct-2011 The Independent
Investment Column:Genus 09-Sep-2011 The Independent
Questor :Dechra Pharmaceuticals 08-Sep-2011 Telegraph

Pharmaceuticals & Biotechnology News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 20,752.30
Closing Price Change 152.27
% Change 0.74 %
27-May-25 Close 20,752.30

Top Risers

Price Change
CIZ 2.05p +13.9%
AVCT 35.20p +13.5%
FARN 245.00p +7.5%
TCF 0.28p +5.1%
POLB 4.00p +3.9%
INDV 888.00p +3.2%
VRCI 1.29p +2.9%
IXI 12.00p +2.1%
HIK 2,156.00p +2.1%
EDEN 3.96p +1.5%

Top Fallers

Price Change
APTA 0.34p -9.0%
LLAI 4.00p -5.9%
HCM 198.50p -5.5%
AGY 7.06p -5.3%
ONT 126.20p -4.3%
SAR 14.40p -4.0%
GENF 0.87p -3.3%
N4P 0.46p -3.2%
AREC 40.40p -2.7%
OXB 320.00p -2.6%

Top of Page